What: During the fifth annual International Conference on Frontiers in Cancer Prevention Research, the American Association for Cancer Research (AACR) is sponsoring a series of press briefings. Following brief presentations by participating investigators, questions will be fielded from members of the press. These briefings are only open to members of the media.

When:"¢ Sunday, November 12- Vaccines to prevent cancer/Update on HPV vaccine: 11:00 " 11:45 a.m.- Biomarkers for early detection of lung, prostate and pancreatic cancer: 1:00 " 1:45 p.m.

"¢ Monday, November 13 - Impact of factors such as gum disease and obesity on cancer risk: 11:00 " 11:45 a.m.- Chemopreventative agents in the pipeline for breast, lung and colon cancer: 1:00 " 1:45 p.m.

"¢ Tuesday, November 14- How dietary choices such as soy and fish may alter cancer risk: 9:00 " 9:45 a.m.- Latest evidence for lowering risk: exercise, aspirin intake, alcohol consumption and giving birth: 11:00 " 11:45 a.m.

Where:Hynes Convention CenterBoston, Mass.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 24,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 70 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts over 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, diagnosis and treatment. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

AACR: International Conference on Frontiers in Cancer Prevention Research